Duclos Philippe, Delo Alison, Aguado Teresa, Bilous Julian, Birmingham Maureen, Kieny Marie Paule, Milstien Julie, Wood David, Tarantola Daniel
Department of Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization-Geneva, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland.
Semin Pediatr Infect Dis. 2003 Jul;14(3):233-9. doi: 10.1016/s1045-1870(03)00038-4.
In 1999, the World Health Organization's (WHO) Department of Vaccines and Biologicals launched the Immunization Safety Priority Project with the aim of establishing a comprehensive system to ensure the safety of all immunizations given in national immunization programs. Countries are the primary focus of the project. WHO has a role, not only because of its technical and normative role, but also because of its privileged relationship with country authorities and other partners, and its global vision and mandate. The four major areas of focus in the project are to (1) promote and coordinate research and development of safer and simpler delivery systems; (2) ensure vaccine safety, from vaccine development all the way through clinical trials and vaccine distribution until use; (3) broaden access to safer and more efficient systems for vaccine delivery and management of sharps waste; and (4) establish efficient mechanisms to detect serious or potentially serious adverse events following immunization, and enable prompt and effective response. The project emphasizes the importance of advocating safety and building capacity at national levels.
1999年，世界卫生组织（WHO）疫苗与生物制品司发起了免疫安全重点项目，旨在建立一个综合系统，以确保国家免疫规划中所有疫苗接种的安全性。各国是该项目的主要关注对象。世卫组织发挥作用，不仅因其技术和规范作用，还因其与国家当局及其他伙伴的特殊关系，以及其全球视野和使命。该项目的四个主要重点领域是：（1）促进和协调更安全、更简便接种系统的研发；（2）确保疫苗安全，从疫苗研发一直到临床试验、疫苗分发直至使用；（3）扩大获得更安全、更高效疫苗接种及锐器废物管理系统的机会；（4）建立有效机制，以检测免疫接种后发生的严重或潜在严重不良事件，并实现迅速、有效的应对。该项目强调在国家层面倡导安全性和建设能力的重要性。
